SOLACI Videos

Caso en Vivo: Implante de válvula aórtica por catéter (TAVI) Programa SOLidario

solaci
solaci
487
0

La Sociedad Latinoamericana de Cardiología Intervencionista relanzó su programa SOLidario practicando exitosamente el implante de una válvula aórtica por catéter (TAVI) en el instituto Angiografia de Occidente de la ciudad de Cali. Fue durante la XXIV edición de Jornadas SOLACI realizadas el 30 y 31 de octubre de 2014 en Colombia.

Previous article
Lower Rates of In-Stent Thrombosis with the New Generation DES
Next article
Target amount for reasonable incomplete revascularization
solaci
solaci

More articles by this author

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

solaci - 0
Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

How to apply for the SOLACI Research 2025 Grant? Step-by-step explanation video

solaci - 0
You can now rewatch the virtual event we held on April 9th, where we thoroughly reviewed the steps to apply for the SOLACI Research...

Watch our event on Evidence and Controversies of Renal Denervation in 2025

solaci - 0
You can now watch our event, held in collaboration with Medtronic, titled "Evidence and Controversies of Renal Denervation in 2025." The event featured international experts...

Watch Angioplasty Techniques for Bifurcations Again From a Completely Different Perspective.

solaci - 0
You can now watch on our YouTube channel the event we held in collaboration with Medtronic, titled: "Visualizations of Different PCI Techniques for Bifurcations...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Institutional News

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19,...
solaci -
SOLACI Sessionsspot_img

Recent Articles

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Dr. Andrés Rodríguez - 0
Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Dr. Juan Manuel Pérez - 0
Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Dr. Juan Manuel Pérez - 0
Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...